# Cognizant: how the business works

> For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

Cognizant Technology Solutions Corporation · NASDAQ: CTSH · Sector: Technology

Updated for Q3 FY2026 · checked Nov 20, 2026

This is the plain-text version of https://cityfort.co/stocks/cognizant. Source ids in [brackets] refer to the list at the end. Credit: "Cityfort, Cognizant: how the business works", with the page URL.

## The 30-second summary

Cognizant, based in Teaneck, New Jersey, is hired by large companies to build and run their software and back-office work, with FY2025 revenue of $21,108 million. North America brought in 74.8% of that revenue, most staff work in India, and $10.5 of every $100 that came in was left as net income. In Q3 FY2026, Financial Services revenue rose 12.0% from a year earlier while Health Sciences revenue fell 1.1%.

## 5 points

- **What it sells:** Cognizant builds, updates and runs software and computer systems for large companies: of $21,108 million of FY2025 revenue, consulting and technology services brought in $13.5 billion and outsourcing $7.6 billion. [S4]
- **Who pays it:** In FY2025, health insurers, hospitals and drug makers paid 30.1% of Cognizant's revenue, banks and insurers 29.2%, manufacturers, retailers and travel firms 25% and telecom, media and tech firms 15.6%. [S4]
- **What it keeps from $100:** Of every $100 that came in during FY2025, Cognizant kept $10.5 as net income, after a one-time $390 million tax charge and including a $62 million office-sale gain; operating income was $16.1 per $100 of revenue. [S4]
- **Where the operating profit comes from:** Health Sciences earned $1,233 million of FY2025 segment operating profit, Financial Services $1,029 million, Products and Resources $787 million and Communications, Media and Technology $436 million. [S4]
- **The one thing to watch:** In Q3 FY2026, Health Sciences revenue fell 1.1% to $1,587 million while Financial Services rose 12.0% to $1,767 million; on Oct 29, 2026, Cognizant said it expects FY2026 revenue of $22.05 billion to $22.14 billion. [S16, S1]

## What does Cognizant sell?

Cognizant is hired by large companies to build, update and run their software and computer systems. Its staff, most of them in India, also handle back-office work such as health insurance claims.

- **Consulting and technology services:** Projects to build or modernize software, cloud systems, data and AI tools. $13.5 billion, 64.1% of FY2025 revenue. [S4]
- **Outsourcing services:** Running clients' applications, IT infrastructure and business processes over several years. $7.6 billion, 35.9% of FY2025 revenue. [S4]
- **Software platforms:** Cognizant develops, licenses and supports software, including the TriZetto platforms health insurers use for claims. [S4, S16]
- **Engineering services:** Engineering research and development for aerospace, defense, space, marine and industrial clients, added with the Belcan purchase in 2024. [S4]

## Who pays Cognizant?

- **Health insurers, hospitals and drug makers (Health Sciences) (30.1% of revenue):** Healthcare providers and payers, plus pharmaceutical, biotech and medical device companies; work includes claims processing and clinical development. [S4]
- **Banks and insurers (Financial Services) (29.2% of revenue):** Banking, capital markets, payments and insurance companies modernizing old systems. [S4]
- **Manufacturers, retailers and travel firms (Products and Resources) (25.0% of revenue):** Manufacturers, automakers, retailers, consumer goods, aerospace and defense, travel, logistics, energy and utility companies. [S4]
- **Telecom, media and tech firms (Communications, Media and Technology) (15.6% of revenue):** Communications, media, education, publishing, information services and technology companies. [S4]
- **Customer concentration:** The FY2025 10-K gives no revenue share for its largest clients. It says losing one or a few significant clients could materially reduce a segment's revenue. [S4]

## Where the money went (FY2025)

1. Clients paid Cognizant $21.1 billion in FY2025 for technology services, consulting and outsourcing.
2. Delivering the work, mostly staff pay, cost $14.0 billion.
3. Selling and administration took $3.2 billion, and depreciation and amortization $550 million.
4. A $62 million gain on selling an India office complex, $90 million of net other income and $9 million from part-owned companies added $161 million.
5. Income tax took $1.26 billion, including a one-time $390 million charge, leaving $2.23 billion of net income.

Sources: S4.

## Key numbers by year (US$ million)

Financials: consolidated, US$ million. Fiscal years are the company's own: Fiscal year ends Dec 31 (the calendar year). — = not shown on the page.

| Year | Revenue | EBITDA | EBITDA margin | Net profit | Net margin | EPS (US$ per share, diluted) | Operating cash flow | Capital spending | Free cash flow | Sources |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| FY2021 | 18,507 | 3,400 | 18.4% | 2,137 | 11.5% | 4.05 | 2,495 | 279 | 2,216 | S14 |
| FY2022 | 19,428 | 3,537 | 18.2% | 2,290 | 11.8% | 4.41 | 2,568 | 332 | 2,236 | S13 |
| FY2023 | 19,353 | 3,244 | 16.8% | 2,126 | 11.0% | 4.21 | 2,330 | 317 | 2,013 | S12 |
| FY2024 | 19,736 | 3,434 | 17.4% | 2,240 | 11.3% | 4.51 | 2,124 | 297 | 1,827 | S8 |
| FY2025 | 21,108 | 3,939 | 18.7% | 2,230 | 10.6% | 4.56 | 2,883 | 288 | 2,595 | S4 |

- EBITDA here = operating income plus depreciation and amortization (from the cash flow statement).
- Net profit is the share belonging to the company's owners.

## Balance sheet (as of Sep 30, 2026, US$ million)

At Sep 30, 2026, Cognizant's cash and short-term investments of $1,552 million equaled its borrowings of $1,552 million. [S1, S22, S33, S32]

| Item | Value |
| --- | --- |
| Total debt | 1,552 |
| Cash and investments | 1,552 |
| Net debt (debt minus cash) | 0 |
| Net worth (shareholders' money) | 14,726 |
| Debt to equity (times) | 0.11 |

- Net debt of zero is a Cityfort calculation from the Q3 FY2026 10-Q: cash of $1,515 million plus $37 million of short-term investments, minus $1,552 million of long-term debt.
- The Q4 FY2025 earnings release states net cash of $1,338 million at Dec 31, 2025. Cash then excluded $733 million held in escrow for the 3Cloud purchase.
- Borrowings rose after a $1.0 billion draw on the revolving credit line on May 20, 2026, tied to buybacks and the Astreya purchase.
- On Oct 5, 2026, Cognizant signed new unsecured facilities: a $550 million term loan and a $1.85 billion revolving line, due Oct 3, 2031.
- Operating lease liabilities ($156 million current and $424 million noncurrent at Sep 30, 2026) are not counted as debt here.
- Goodwill from acquisitions was $8.1 billion of $21.3 billion of total assets at Sep 30, 2026.
- Other assets include a $360 million deposit with India's Income Tax Department, paid during a tax dispute.

## Who owns Cognizant? (as of Apr 6, 2026)

Cognizant has one class of stock with one vote per share, so no single holder controls the votes. Directors and executive officers as a group (20 people) did not own more than 1% at Apr 6, 2026. Vanguard told the company on Mar 26, 2026 that its units now report holdings separately. [S15, S1]

| Class | Shares (millions) | Votes per share | % of shares | % of votes | Traded | Sources |
| --- | --- | --- | --- | --- | --- | --- |
| Class A common stock (Shares outstanding at Sep 30, 2026 (Q3 FY2026 10-Q), down from 479 million at Dec 31, 2025 after buybacks. Traded on Nasdaq as CTSH.) | 448 | 1 | — | — | Yes | S1, S4 |

Holders of 5% or more (each row shows the date of its own filing):

| Holder | Shares | Votes | As of | Note | Sources |
| --- | --- | --- | --- | --- | --- |
| BlackRock, Inc. | 9.0% | — | Apr 24, 2025 | 42,418,452 shares, from a Schedule 13G/A filed Apr 24, 2025, as listed in the 2026 proxy statement. | S15 |
| State Street Corporation | 5.3% | — | Oct 17, 2024 | 24,989,996 shares, from a Schedule 13G filed Oct 17, 2024, as listed in the 2026 proxy statement. | S15 |

## What could go wrong

### Contracts clients can cut

Many contracts are short-term or can be ended on short notice, the FY2025 10-K says. Health Sciences revenue fell 1.1% in Q3 FY2026. [S4, S16]

What to watch: Segment revenue growth each quarter, especially Health Sciences.

### AI changing the work

The FY2025 10-K lists AI use and fast technology change among its risks. Q3 FY2026 bookings fell 7% from a year earlier. [S4, S16]

What to watch: Bookings and the number of large deals in each earnings release.

### Rupee and other currencies

About 23% of 2025 operating costs were in Indian rupees, while most revenue is in US dollars. The 10-K says these costs move with exchange rates. [S4]

What to watch: The rupee-dollar rate and the operating margin.

### Visa and outsourcing rules

Of 351,600 staff at Dec 31, 2025, 256,900 were in India. The Q3 FY2026 10-Q names visa limits in the US, UK and EU and anti-outsourcing laws as risks. [S4, S1]

What to watch: US, UK and EU visa rule changes and their cost.

### Dependence on North America

North America brought in 74.8% of FY2025 revenue. [S4]

What to watch: North America revenue growth in each quarter.

### Indian tax dispute

India's Income Tax Department claims about $344 million more tax on a 2016 share buyback by Cognizant's Indian unit. Cognizant has deposited $360 million; the case is before the High Court and no reserve is recorded. [S1]

What to watch: High Court rulings in the dispute.

### Discrimination class action

A 2017 class action alleges race and national-origin discrimination. A jury found for the plaintiffs in October 2024; the company disputes class certification, and damages are not yet decided. [S1, S4]

What to watch: The company said in its Q3 FY2026 10-Q (Oct 29, 2026) that a trial on certain non-class claims in the race and national-origin discrimination case is scheduled for Dec 8, 2026, and that, separately, the case will proceed to a second phase to determine individual liability and damages, if any.

### Acquisitions and restructuring

Cognizant bought 3Cloud and Astreya in 2026 for purchase prices totalling $1,398 million, including contingent consideration. The Q3 FY2026 10-Q (Oct 29, 2026) puts the total cost of the Project Leap restructuring at $180 million to $250 million. [S1]

What to watch: Acquired revenue growth and Project Leap charges in each 10-Q.

## What to watch

Next: Q4 FY2026 results, Date not announced yet.

- **Healthcare clients:** Health Sciences revenue fell 1.1% in Q3 FY2026 to $1,587 million; the Q3 FY2026 10-Q cites weaker healthcare clients in North America.
- **FY2026 revenue against the range:** On Oct 29, 2026, Cognizant said it expects FY2026 revenue of $22.05 billion to $22.14 billion. The year ends Dec 31, 2026.
- **Project Leap charges:** Restructuring charges reached $135 million in the first nine months of 2026; the Q3 FY2026 10-Q puts the total at $180 million to $250 million.
- **The discrimination class action:** A trial on certain non-class claims in the case alleging race and national-origin discrimination is set for Dec 8, 2026; damages are not yet decided.

## Sources

- S1: Form 10-Q for Q3 FY2026. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000041/0001058290-26-000041-index.htm (published Oct 29, 2026)
- S2: Form 10-Q for Q2 FY2026. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000031/0001058290-26-000031-index.htm (published Jul 29, 2026)
- S3: Form 10-Q for Q1 FY2026. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000016/0001058290-26-000016-index.htm (published Apr 29, 2026)
- S4: Form 10-K for FY2025. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000008/0001058290-26-000008-index.htm (published Feb 12, 2026)
- S5: Form 10-Q for Q3 FY2025. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829025000341/0001058290-25-000341-index.htm (published Oct 29, 2025)
- S6: Form 10-Q for Q2 FY2025. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829025000267/0001058290-25-000267-index.htm (published Jul 31, 2025)
- S7: Form 10-Q for Q1 FY2025. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829025000125/0001058290-25-000125-index.htm (published May 1, 2025)
- S8: Form 10-K for FY2024. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829025000017/0001058290-25-000017-index.htm (published Feb 12, 2025)
- S9: Form 10-Q for Q3 FY2024. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829024000327/0001058290-24-000327-index.htm (published Oct 31, 2024)
- S10: Form 10-Q for Q2 FY2024. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829024000242/0001058290-24-000242-index.htm (published Aug 1, 2024)
- S11: Form 10-Q for Q1 FY2024. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829024000116/0001058290-24-000116-index.htm (published May 2, 2024)
- S12: Form 10-K for FY2023. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829024000017/0001058290-24-000017-index.htm (published Feb 14, 2024)
- S13: Form 10-K for FY2022. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829023000027/0001058290-23-000027-index.htm (published Feb 15, 2023)
- S14: Form 10-K for FY2021. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829022000023/0001058290-22-000023-index.htm (published Feb 16, 2022)
- S15: 2026 Proxy statement (DEF 14A). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000130817926000290/ctsh014861-def14a.htm (published Apr 17, 2026)
- S16: Q3 FY2026 earnings release (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000039/exhibit9919302026.htm (published Oct 29, 2026)
- S17: Q3 FY2026 earnings supplement (8-K Ex. 99.3). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000039/exhibit9939302026.htm (published Oct 29, 2026)
- S18: Q2 FY2026 earnings release (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000030/exhibit9916302026.htm (published Jul 29, 2026)
- S19: Q2 FY2026 earnings supplement (8-K Ex. 99.3). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000030/exhibit9936302026.htm (published Jul 29, 2026)
- S20: Q1 FY2026 earnings release (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000015/exhibit9913312026.htm (published Apr 29, 2026)
- S21: Q1 FY2026 earnings supplement (8-K Ex. 99.3). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000015/exhibit9933312026.htm (published Apr 29, 2026)
- S22: Q4 FY2025 earnings release (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000003/exhibit99112312025.htm (published Feb 4, 2026)
- S23: Q4 FY2025 earnings supplement (8-K Ex. 99.3). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000003/exhibit99312312025.htm (published Feb 4, 2026)
- S24: Q3 FY2025 earnings release (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829025000338/exhibit9919302025.htm (published Oct 29, 2025)
- S25: Q3 FY2025 earnings supplement (8-K Ex. 99.3). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829025000338/exhibit9939302025.htm (published Oct 29, 2025)
- S26: Q2 FY2025 earnings release (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829025000266/exhibit9916302025.htm (published Jul 30, 2025)
- S27: Q2 FY2025 earnings supplement (8-K Ex. 99.3). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829025000266/exhibit9936302025.htm (published Jul 30, 2025)
- S28: Q1 FY2025 earnings release (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829025000124/exhibit9913312025.htm (published Apr 30, 2025)
- S29: Q1 FY2025 earnings supplement (8-K Ex. 99.3). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829025000124/exhibit9933312025.htm (published Apr 30, 2025)
- S30: Q4 FY2024 earnings release (8-K Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829025000007/exhibit99112312024.htm (published Feb 5, 2025)
- S31: Q4 FY2024 earnings supplement (8-K Ex. 99.3). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829025000007/exhibit99312312024.htm (published Feb 5, 2025)
- S32: 8-K Oct 6, 2026 (credit agreement, Items 1.01/2.03). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000033/ctsh-20261005.htm (published Oct 6, 2026)
- S33: 8-K May 21, 2026 (Item 2.03). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000020/ctsh-20260515.htm (published May 21, 2026)
- S34: 8-K May 18, 2026 press release, $2B buyback increase (Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000018/exhibit99151726.htm (published May 18, 2026)
- S35: 8-K Jul 10, 2026 derivative settlement notice (Ex. 99.1). SEC EDGAR. https://www.sec.gov/Archives/edgar/data/1058290/000105829026000025/exhibit991.htm (published Jul 10, 2026)
